Acorn Regulatory is pleased to announce the expansion of its EU Medical Device Vigilance Reporting services, helping medical device manufacturers navigate increasingly complex regulatory requirements under the European Union Medical Device Regulation (EU MDR 2017/745). The enhanced service offering is designed to support organisations in maintaining compliance, protecting patient safety, and responding effectively to post-market regulatory obligations.

As regulatory expectations continue to evolve, manufacturers are required to implement comprehensive medical device safety reporting systems that enable the timely identification, investigation, and reporting of serious incidents and Field Safety Corrective Actions (FSCAs). Acorn Regulatory provides expert guidance throughout the vigilance reporting process, helping clients establish robust procedures that align with current EU MDR requirements.

The company's experienced regulatory professionals work closely with manufacturers to develop compliant complaint handling processes, conduct incident assessments, prepare regulatory submissions, manage post-market surveillance activities, and strengthen quality management systems. These services help organisations reduce regulatory risk while improving operational efficiency and inspection readiness.

In addition to medical device regulatory support, Acorn Regulatory also delivers specialist pharmacovigilance services for pharmaceutical and biotechnology companies. These services include adverse event reporting, Individual Case Safety Report (ICSR) management, Risk Management Plans (RMPs), Periodic Safety Update Reports (PSURs), signal detection, and regulatory compliance support throughout the medicinal product lifecycle.

As one of the trusted regulatory consultancies serving clients across Ireland, the United Kingdom, Europe, and international markets, Acorn Regulatory provides tailored regulatory strategies that support product development, market access, and ongoing compliance. The consultancy works with organisations ranging from innovative start-ups to established global manufacturers, offering practical solutions that address evolving regulatory challenges.

"Our goal is to help clients achieve regulatory compliance efficiently while maintaining the highest standards of patient safety and product quality," said a spokesperson for Acorn Regulatory. "By combining regulatory expertise with a practical, client-focused approach, we enable organisations to navigate complex compliance requirements with confidence."

With growing global emphasis on post-market surveillance, vigilance reporting, and proactive risk management, Acorn Regulatory remains committed to delivering high-quality regulatory consulting services that help healthcare companies bring safe, effective products to market while meeting the expectations of regulatory authorities.

About Acorn Regulatory

Acorn Regulatory is a specialist regulatory affairs consultancy providing expert support to pharmaceutical, biotechnology, medical device, and in vitro diagnostic companies. The company offers services including EU Medical Device Vigilance Reporting, medical device safety reporting, pharmacovigilance services, regulatory strategy, quality management systems, post-market surveillance, clinical evaluation, eCTD publishing, audit preparation, and global regulatory compliance. Acorn Regulatory partners with organisations across Ireland, the United Kingdom, Europe, and international markets to deliver practical regulatory solutions that support compliance, patient safety, and successful market access.